Extracellular Vesicles: A Double-Edged Sword in Sepsis

被引:36
|
作者
Burgelman, Marlies [1 ,2 ]
Vandendriessche, Charysse [1 ,2 ]
Vandenbroucke, Roosmarijn E. [1 ,2 ]
机构
[1] VIB Ctr Inflammat Res, B-9052 Ghent, Belgium
[2] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium
关键词
extracellular vesicles; sepsis; inflammation; TISSUE FACTOR ACTIVITY; SEPTIC SHOCK; CIRCULATING MICROPARTICLES; ORGAN DYSFUNCTION; ENDOTHELIAL MICROPARTICLES; POSITIVE MICROPARTICLES; PLATELET MICROPARTICLES; COAGULATION ACTIVATION; CELLULAR-ORIGIN; MESSENGER-RNA;
D O I
10.3390/ph14080829
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host response to an infection. Several studies on mouse and patient sepsis samples have revealed that the level of extracellular vesicles (EVs) in the blood is altered compared to healthy controls, but the different functions of EVs during sepsis pathology are not yet completely understood. Sepsis EVs are described as modulators of inflammation, lymphocyte apoptosis, coagulation and organ dysfunction. Furthermore, EVs can influence clinical outcome and it is suggested that EVs can predict survival. Both detrimental and beneficial roles for EVs have been described in sepsis, depending on the EV cellular source and the disease phase during which the EVs are studied. In this review, we summarize the current knowledge of EV sources and functions during sepsis pathology based on in vitro and mouse models, as well as patient samples.
引用
收藏
页数:40
相关论文
共 50 条
  • [21] Inflammatory angiogenesis in atherogenesisa double-edged sword
    Ribatti, Domenico
    Levi-Schaffer, Francesca
    Kovanen, Petri T.
    ANNALS OF MEDICINE, 2008, 40 (08) : 606 - 621
  • [22] Chemotherapy: a double-edged sword in cancer treatment
    Nafiseh Behranvand
    Farzad Nasri
    Reza Zolfaghari Emameh
    Pouria Khani
    Asieh Hosseini
    Johan Garssen
    Reza Falak
    Cancer Immunology, Immunotherapy, 2022, 71 : 507 - 526
  • [23] Viruses, apoptosis, and neuroinflammation—a double-edged sword
    Peter G. E. Kennedy
    Journal of NeuroVirology, 2015, 21 : 1 - 7
  • [24] Mast cells: A double-edged sword in cancer
    Derakhshani, Afshin
    Vahidian, Fatemeh
    Alihasanzadeh, Mohammad
    Mokhtarzadeh, Ahad
    Nezhad, Parisa Lotfi
    Baradaran, Behzad
    IMMUNOLOGY LETTERS, 2019, 209 : 28 - 35
  • [25] Chemotherapy: a double-edged sword in cancer treatment
    Behranvand, Nafiseh
    Nasri, Farzad
    Emmameh, Zolfaghari
    Khani, Pouria
    Hosseini, Asieh
    Garssen, Johan
    Falak, Reza
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (03) : 507 - 526
  • [26] RNA Is a Double-Edged Sword in ALS Pathogenesis
    Zaepfel, Benjamin L.
    Rothstein, Jeffrey D.
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2021, 15
  • [27] Platelets in Thrombosis and Atherosclerosis A Double-Edged Sword
    Bravo, Gabriela Martinez
    Annarapu, Gowtham
    Carmona, Emely
    Nawarskas, James
    Clark, Ross
    Novelli, Enrico
    Alvidrez, Roberto I. Mota
    AMERICAN JOURNAL OF PATHOLOGY, 2024, 194 (09) : 1608 - 1621
  • [28] Angiotensin II: A double-edged sword in inflammation
    Suzuki, Y
    Ruiz-Ortega, M
    Egido, J
    JOURNAL OF NEPHROLOGY, 2000, 13 : S101 - S110
  • [29] Exosomes: a double-edged sword in cancer immunotherapy
    Chen, Jiayi
    Hu, Siyuan
    Liu, Jiayi
    Jiang, Hao
    Wang, Simiao
    Yang, Zhaogang
    MEDCOMM, 2025, 6 (03):
  • [30] Interleukin 27: a double-edged sword for offense and defense
    Yoshida, Hiroki
    Nakaya, Mako
    Miyazaki, Yoshiyuki
    JOURNAL OF LEUKOCYTE BIOLOGY, 2009, 86 (06) : 1295 - 1303